S. Engelborghs

2.2k total citations
26 papers, 1.0k citations indexed

About

S. Engelborghs is a scholar working on Physiology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, S. Engelborghs has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Neurology and 6 papers in Psychiatry and Mental health. Recurrent topics in S. Engelborghs's work include Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (5 papers) and Stroke Rehabilitation and Recovery (4 papers). S. Engelborghs is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (5 papers) and Stroke Rehabilitation and Recovery (4 papers). S. Engelborghs collaborates with scholars based in Belgium, Netherlands and Italy. S. Engelborghs's co-authors include Peter Paul De Deyn, Rudi D’Hooge, Peter Mariën, Raf Brouns, Erik Fransén, Barbara Pickut, Patrick Santens, G.R. Castro, Christine Labeur and M. Rosseneu and has published in prestigious journals such as Annals of Neurology, Journal of Lipid Research and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

S. Engelborghs

25 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Engelborghs Belgium 16 375 254 251 223 196 26 1.0k
Sigrid Botne Sando Norway 22 649 1.7× 384 1.5× 302 1.2× 242 1.1× 228 1.2× 41 1.3k
Domenico Lupoi Italy 23 471 1.3× 100 0.4× 118 0.5× 181 0.8× 342 1.7× 31 1.4k
Benjamin F. Gruenbaum United States 24 223 0.6× 127 0.5× 362 1.4× 275 1.2× 307 1.6× 91 1.5k
Kenji Wada‐Isoe Japan 20 271 0.7× 272 1.1× 349 1.4× 409 1.8× 151 0.8× 44 1.2k
Neda Minakaran United Kingdom 7 326 0.9× 378 1.5× 138 0.5× 122 0.5× 224 1.1× 19 1.1k
Burak Yuluğ Türkiye 21 217 0.6× 94 0.4× 314 1.3× 269 1.2× 378 1.9× 86 1.3k
Catrina Sims‐Robinson United States 17 502 1.3× 79 0.3× 399 1.6× 85 0.4× 213 1.1× 24 1.2k
Kathryn Nichol United States 11 528 1.4× 241 0.9× 238 0.9× 75 0.3× 253 1.3× 18 1.2k
Daniel Vardeh United States 9 970 2.6× 181 0.7× 321 1.3× 187 0.8× 182 0.9× 11 1.5k
Vanessa de Jesus Rodrigues de Paula Brazil 17 588 1.6× 325 1.3× 371 1.5× 95 0.4× 167 0.9× 37 1.4k

Countries citing papers authored by S. Engelborghs

Since Specialization
Citations

This map shows the geographic impact of S. Engelborghs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Engelborghs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Engelborghs more than expected).

Fields of papers citing papers by S. Engelborghs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Engelborghs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Engelborghs. The network helps show where S. Engelborghs may publish in the future.

Co-authorship network of co-authors of S. Engelborghs

This figure shows the co-authorship network connecting the top 25 collaborators of S. Engelborghs. A scholar is included among the top collaborators of S. Engelborghs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Engelborghs. S. Engelborghs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brouns, Raf, S. Engelborghs, M. Ieven, et al.. (2017). Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood–brain barrier dysfunction. Journal of Thrombosis and Haemostasis. 16(2). 342–348. 16 indexed citations
2.
Fransén, Erik, et al.. (2014). Poststroke depression and its multifactorial nature: Results from a prospective longitudinal study. Journal of the Neurological Sciences. 347(1-2). 159–166. 72 indexed citations
3.
Brouns, Raf, et al.. (2013). A Prospective Study on the Prevalence and Risk Factors of Poststroke Depression. Cerebrovascular Diseases Extra. 3(1). 1–13. 68 indexed citations
4.
Fransén, Erik, et al.. (2013). Psychosocial problems associated with depression at 18 months poststroke. International Journal of Geriatric Psychiatry. 29(2). 144–152. 29 indexed citations
5.
Azermai, Majda, Mirko Petrović, S. Engelborghs, et al.. (2012). The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: A pilot study. Aging & Mental Health. 17(1). 125–132. 15 indexed citations
6.
Dierckx, Eva, S. Engelborghs, Rudi De Raedt, et al.. (2009). Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment. International Journal of Geriatric Psychiatry. 24(10). 1094–1100. 39 indexed citations
7.
Mariën, Peter, Raf Brouns, S. Engelborghs, Peggy Wackenier, & Peter Paul De Deyn. (2008). Cerebellar cognitive-affective syndrome without mental retardation in two patients with Gillespie syndrome.. Cortex. 54–67. 1 indexed citations
8.
Gebruers, Nick, Steven Truijen, Guy Nagels, et al.. (2008). Actigraphic measurement of motor deficits in acute ischaemic. Journal of Neurology. 255. 40–41. 1 indexed citations
9.
Nagels, Guy, Marie D’hooghe, Daphne Kos, S. Engelborghs, & Peter Paul De Deyn. (2007). Within-session practice effect on paced auditory serial addition test in multiple sclerosis. Multiple Sclerosis Journal. 14(1). 106–111. 9 indexed citations
10.
Dam, Debby Van, Bart Marescau, T.I.F.H. Cremers, et al.. (2005). Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain. Amino Acids. 28(4). 377–387. 4 indexed citations
11.
Dermaut, Bart, Samir Kumar‐Singh, S. Engelborghs, et al.. (2004). A novel presenilin 1 mutation associated with Pick's disease but not β‐amyloid plaques. Annals of Neurology. 55(5). 617–626. 147 indexed citations
12.
Vloeberghs, Ellen, Debby Van Dam, S. Engelborghs, et al.. (2004). P68 ALTERED CIRCADIAN LOCOMOTOR ACTIVITY IN APP23 MICE: A MODEL FOR BPSD DISTURBANCES. Behavioural Pharmacology. 15(5). A28–A28. 1 indexed citations
13.
Engelborghs, S.. (2003). Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. Journal of Neurology Neurosurgery & Psychiatry. 74(8). 1148–1151. 97 indexed citations
14.
Engelborghs, S., et al.. (2002). REPLY. European Journal of Neurology. 9(6). 702–702. 1 indexed citations
15.
Mariën, Peter, S. Engelborghs, & Peter Paul De Deyn. (2001). Cerebellar neurocognition: a new avenue.. PubMed. 101(2). 96–109. 23 indexed citations
16.
Mariën, Peter, S. Engelborghs, L.A. Vignolo, & Peter Paul De Deyn. (2001). The many faces of crossed aphasia in dextrals: report of nine cases and review of the literature. European Journal of Neurology. 8(6). 643–658. 32 indexed citations
17.
Banchaabouchi, Mumna Al, Bart Marescau, Rudi D’Hooge, S. Engelborghs, & Peter Paul De Deyn. (2000). Consequences of renal mass reduction on amino acid and biogenic amine levels in nephrectomized mice. Amino Acids. 18(3). 265–277. 14 indexed citations
18.
Engelborghs, S., Rudi D’Hooge, & Peter Paul De Deyn. (2000). Pathophysiology of epilepsy.. PubMed. 100(4). 201–13. 98 indexed citations
19.
Deyn, P. De, S. Engelborghs, Ehud Hauben, et al.. (1999). From Neuronal and Vascular Impairment to Dementia. Pharmacopsychiatry. 32(S 1). 17–24. 25 indexed citations
20.
Engelborghs, S., M. De Brabander, J. De Crée, et al.. (1999). Unchanged levels of interleukins, neopterin, interferon-γ and tumor necrosis factor-α in cerebrospinal fluid of patients with dementia of the Alzheimer type. Neurochemistry International. 34(6). 523–530. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026